Novitium Pharma recalls
FDA enforcement reports naming Novitium Pharma LLC as the recalling firm.
- Recall reports
- 6
- Class I (serious)
- 0
- Most recent report
- Apr 24, 2024
- Apr 24, 2024Digoxin Tablets, USP 62Drug · Novitium Pharma LLCFailed Impurities/Degradation SpecificationsClass III
- Mar 27, 2024Digoxin Tablets, USP 125mcg, (0Drug · Novitium Pharma LLCCross Contamination with Other Products:(mycophenolate mofetil).Class III
- Nov 20, 2019Novitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured by: Noviti…Drug · Novitium Pharma LLCCGMP Deviations: Presence of NDMA impurity detected in product.Class II
- Nov 20, 2019Novitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured by: Novitiu…Drug · Novitium Pharma LLCCGMP Deviations: Presence of NDMA impurity detected in product.Class II
- Nov 20, 2019Novitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Noviti…Drug · Novitium Pharma LLCCGMP Deviations: Presence of NDMA impurity detected in product.Class II
- Nov 20, 2019Novitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured by: Novitiu…Drug · Novitium Pharma LLCCGMP Deviations: Presence of NDMA impurity detected in product.Class II